 The problem we have, though, with the regulation is that the FDA itself, in the way that they have misused this regulation, is they are not only stymieing innovation and technologies, they're also killing any incentive for a U.S. company to set up operations here and to manufacture products here. And the reason for that is there is just no clear path.